Intermittent fasting (IF) has gained popularity not just as a weight management strategy but also for its potential therapeutic benefits in preventing serious health conditions such as liver disease and cancer. Recent research conducted by the German Cancer Research Center (DKFZ) and the University of Tübingen highlights the remarkable effects of a 5:2 intermittent fasting schedule on liver health, offering hope for millions suffering from fatty liver disease and its severe consequences.